Immunoprecise Antibodies Ltd
XTSX:IPA
Immunoprecise Antibodies Ltd
XTSX:IPA
Price:
6.5 CAD
0.78%
Market Closed
Updated:
May 10, 2024
Immunoprecise Antibodies Ltd
Selling, General & Administrative
|
Immunoprecise Antibodies Ltd
Selling, General & Administrative Peer Comparison
Comparables:
ABCL
ARCH
RP
IOT
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Immunoprecise Antibodies Ltd
XTSX:IPA
|
Selling, General & Administrative
-CA$13.8m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abcellera Biologics Inc
NASDAQ:ABCL
|
Selling, General & Administrative
-$75.2m
|
CAGR 3-Years
-68%
|
CAGR 5-Years
-92%
|
CAGR 10-Years
N/A
|
|
|
Arch Biopartners Inc
XTSX:ARCH
|
Selling, General & Administrative
-CA$4.5m
|
CAGR 3-Years
3%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-37%
|
|
|
Replicel Life Sciences Inc
XTSX:RP
|
Selling, General & Administrative
-CA$1.2m
|
CAGR 3-Years
2%
|
CAGR 5-Years
9%
|
CAGR 10-Years
7%
|
|
|
Innovotech Inc
XTSX:IOT
|
Selling, General & Administrative
-CA$1m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
0%
|
See Also
What is Immunoprecise Antibodies Ltd's Selling, General & Administrative?
Selling, General & Administrative
-13.8m
CAD
-13.8m
CAD
Based on the financial report for Apr 30, 2021, Immunoprecise Antibodies Ltd's Selling, General & Administrative amounts to -13.8m CAD.
What is Immunoprecise Antibodies Ltd's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 3Y
-28%
-28%
Over the last year, the Selling, General & Administrative growth was -51%. The average annual Selling, General & Administrative growth rates for Immunoprecise Antibodies Ltd have been -28% over the past three years .
You don't have any saved screeners yet
